GGrantIndex
← Leaderboards

University Of Texas Dallas

Richardson, TX

Compare ↔
$312,798,758
Total funding
315
Grants

Funding over time

peak $38.5M · FY2005–25
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$313,106,758 · 316

By mechanism

R01$190,414,453 · 123
R35$23,844,007 · 18
R21$17,377,938 · 45
RF1$16,208,149 · 4
U19$9,187,121 · 10
R00$9,163,548 · 14

Investigators at University Of Texas Dallas

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Xintong Dong$1,218,3311 gr2Polimyr Caesar Dave Pelisco Dingal$1,077,6001 gr3Yongsheng Gao$985,4602 gr4Munmun Chattopadhyay$945,4091 gr5Muhammad Saad Yousuf$945,4091 gr6Hui Ouyang$819,0002 gr7Filippo Romiti$780,0001 gr8Hedieh Torabifard$765,7081 gr

Emerging Leaders

6–10 yrs in

1Zhenpeng Qin$7,891,8328 gr2Taylor H Ware$4,245,3584 gr3Danieli Rodrigues$3,291,4651 gr4Gagan S Wig$3,275,7992 gr5Gabriele Meloni$3,096,1161 gr6Nicole Janell De Nisco$2,670,7654 gr7Alonso Faruck Morcos$2,514,7321 gr8Sheena D'arcy$2,474,9201 gr

All-Time

Most funded here, all years

1Santosh R D'mello$9,386,17610 gr2Zhenpeng Qin$7,891,8328 gr3Marion K. Underwood$7,070,1615 gr4Kenneth Hoyt$6,537,4695 gr5Gregory O Dussor$5,582,60210 gr6Anu Sharma$5,405,6034 gr7Karen M Rodrigue$5,008,3523 gr8Jie Zheng$4,990,0885 gr

Largest grants

Dallas Lifespan Brain Study-Wave 3: Neurodegeneration & Resilience in Cognition$5,755,201
RF1 · FY2017 · AG
A fully humanized functional genomic screen to identify and validate pain therapeutic targets$4,039,366
RF1 · FY2025 · NS
Relationship Between Neural Correlates of Episodic Memory,Age, Memory Performance$2,674,253
RF1 · FY2017 · AG
Development of new photo-releasable neuropeptide nano-vesicles for studying modulation in the brain$2,399,777
RF1 · FY2019 · NS
Human Nociceptor and Spinal Cord Molecular Signature Center$2,367,318
U19 · FY2022 · NS
Human Nociceptor and Spinal Cord Molecular Signature Center$2,326,302
U19 · FY2024 · NS
PHASE-BASED CONTROL OF LOCOMOTION FOR HIGH-PERFORMANCE PROSTHESES AND ORTHOSES$2,295,000
DP2 · FY2013 · HD
Human Nociceptor and Spinal Cord Molecular Signature Center$2,274,199
U19 · FY2023 · NS
Human Nociceptor and Spinal Cord Molecular Signature Center$2,219,302
U19 · FY2025 · NS
Impact of challenging engagement on cognition in older adults: A clinical trial$1,266,382
R56 · FY2018 · AG
Enhancing recovery of lower limb function after spinal cord injury$1,177,221
UG3 · FY2024 · NS
Wireless Nerve Stimulation Device To Enhance Recovery After Stroke$1,169,842
UH3 · FY2021 · NS
Enhancing recovery of lower limb function after spinal cord injury$1,163,868
UG3 · FY2025 · NS
Wireless Nerve Stimulation Device To Enhance Recovery After Stroke$1,156,520
UH3 · FY2022 · NS
Wireless Nerve Stimulation Device To Enhance Recovery After Stroke$1,082,420
UH3 · FY2023 · NS
Neuroimaging of Dedifferentiation and Memory Across the Lifespan$985,846
R37 · FY2014 · AG
Neuroimaging of Dedifferentiation and Memory Across the Lifespan$953,505
R37 · FY2015 · AG
Neuroimaging of Dedifferentiation and Memory Across the Lifespan$894,213
R37 · FY2009 · AG
Caregiver Speech and Brain-Behavior Development in Infants At-Risk for ASD$844,756
R01 · FY2022 · DC
Dallas Lifespan Brain Study-Wave 3: Neurodegeneration & Resilience in Cognition$836,653
RF1 · FY2018 · AG